Hosted on MSN2mon
I-Mab pauses CD73 antibody development in pipeline reshuffleUliledlimab is an antibody designed to target CD73. The development pause will ... such as those with low levels of CLDN18.2 expression that would not qualify for approved CLDN18.2 therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback